XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Reportable Segment Information
Reportable segment information was as follows:
 Three Months EndedSix Months Ended
June 30,June 30,
(DOLLARS IN MILLIONS)2023202220232022
Net sales:
Nourish$1,564 $1,818 $3,217 $3,549 
Health & Biosciences522 665 1,035 1,326 
Scent592 580 1,200 1,165 
Pharma Solutions251 244 504 493 
Consolidated$2,929 $3,307 $5,956 $6,533 
Segment Adjusted Operating EBITDA:
Nourish$181 $365 $389 $694 
Health & Biosciences145 184 276 376 
Scent117 93 222 209 
Pharma Solutions67 58 126 123 
Total510 700 1,013 1,402 
Depreciation & Amortization(287)(301)(563)(604)
Interest Expense(116)(77)(227)(149)
Other Income (Expense), net21 (6)15 10 
Restructuring and Other Charges (a)(7)(7)(59)(9)
Impairment of Long-Lived Assets (b)— (120)— (120)
Acquisition, Divestiture and Integration Related Costs (c)(45)(61)(76)(110)
Strategic Initiatives Costs (d)(9)— (22)— 
Regulatory Costs (e)(14)— (19)— 
Other (f)(3)2 2 (5)
Income Before Taxes$50 $130 $64 $415 
_______________________
(a)For 2023 and 2022, represents costs primarily related to severance as part of the Company's restructuring efforts.
(b)Represents costs related to the impairment of intangible and fixed assets of an asset group that operated primarily in Russia.
(c)
For 2023 and 2022, primarily represents costs related to the Company's actual and planned acquisitions and divestitures and integration related activities primarily for Frutarom and N&B. These costs primarily consisted of external consulting fees, professional and legal fees and salaries of individuals who are fully dedicated to such efforts. For 2023, acquisition costs primarily relate to earn-out adjustments and integration costs primarily relate to IT costs for the N&B integration.

For the three months ended June 30, 2023, business divestiture, integration and acquisition related costs were approximately $20 million, $20 million and $5 million, respectively. For the three months ended June 30, 2022, business divestiture, integration and acquisition related costs were approximately $30 million, $30 million and $1 million, respectively. For the six months ended June 30, 2023, business divestiture, integration and acquisition related costs were approximately $41 million, $30 million and $5 million, respectively. For the six months ended June 30, 2022, business divestiture, integration and acquisition related costs were approximately $60 million, $48 million and $2 million, respectively.
(d)Represents costs related to the Company's strategic assessment and business portfolio optimization efforts and reorganizing the Global Shared Services Centers, primarily consulting fees.
(e)Represents costs primarily related to legal fees incurred for the ongoing investigations of the fragrance businesses.
(f)For 2023, represents (losses) gains from sale of assets. For 2022, represents shareholder activist related costs, primarily professional fees, severance costs, including accelerated stock compensation expense, for certain executives who have been separated from the Company, and gains from sale of assets.
Net Sales by Destination of Product Delivery
Net sales, which are attributed to individual regions based upon the destination of product delivery, were as follows:
 Three Months Ended June 30,Six Months Ended June 30,
(DOLLARS IN MILLIONS)2023202220232022
Europe, Africa and Middle East$970 $1,100 $2,040 $2,228 
Greater Asia673 755 1,361 1,499 
North America910 1,065 1,815 2,067 
Latin America376 387 740 739 
Consolidated$2,929 $3,307 $5,956 $6,533 
 Three Months Ended June 30,Six Months Ended June 30,
(DOLLARS IN MILLIONS)2023202220232022
Net sales related to the U.S.$777 $978 $1,648 $1,879 
Net sales attributed to all foreign countries2,152 2,329 4,308 4,654